Literature DB >> 2223417

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

P H Joubert1, H L Venter, G N Foukaridis.   

Abstract

1. Alpha-glucosidase inhibitors such as miglitol and acarbose lower blood glucose after a starch load in healthy volunteers and diabetic patients by interfering with the conversion of disaccharide to monosaccharide in the gastrointestinal tract. 2. The effect of placebo, 100 mg miglitol and 100 mg acarbose given 30 min prior to a 75 g oral glucose load was investigated in nine healthy Caucasian volunteers. 3. Miglitol produced a statistically significant fall in post-peak blood glucose levels when compared with placebo and acarbose. Serum insulin did not change significantly. 4. As miglitol is well absorbed and acarbose is not, it is suggested that miglitol has a systemic hypoglycaemic effect, probably related to its close structural similarity to glucose, which warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223417      PMCID: PMC1368141          DOI: 10.1111/j.1365-2125.1990.tb03789.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.

Authors:  P H Joubert; G N Foukaridis; M L Bopape
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

Authors:  C Schnack; G Röggla; A Luger; G Schernthaner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man.

Authors:  I Hillebrand; K Boehme; K H Graefe; K Wehling
Journal:  Klin Wochenschr       Date:  1986-04-15

4.  Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.

Authors:  R J Walton; I T Sherif; G A Noy; K G Alberti
Journal:  Br Med J       Date:  1979-01-27

5.  The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers.

Authors:  P H Joubert; C P Venter; H F Joubert; I Hillebrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  5 in total
  16 in total

Review 1.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Authors:  L J Scott; C M Spencer
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  Inhibition of small-intestinal sugar absorption mediated by sodium orthovanadate Na3VO4 in rats and its mechanisms.

Authors:  Jing Ai; Jie Du; Ning Wang; Zhi-Min Du; Bao-Feng Yang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 3.  Additive contribution of multiple factors in the development of pneumatosis intestinalis: a case report and review of the literature.

Authors:  Masataka Saito; Akiko Tanikawa; Katsuki Nakasute; Masaru Tanaka; Takeji Nishikawa
Journal:  Clin Rheumatol       Date:  2006-01-11       Impact factor: 2.980

Review 4.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 5.  Drug therapy of postprandial hyperglycaemia.

Authors:  A D Mooradian; J E Thurman
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 6.  A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.

Authors:  F Santeusanio; P Compagnucci
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 7.  Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors.

Authors:  H E Lebovitz
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Clinical significance of cardiovascular dysmetabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-01-07

9.  Pneumatosis cystoides intestinalis of the ascending colon related to acarbose treatment: a case report.

Authors:  Yilin Vogel; Nikolaus J Buchner; Michael Szpakowski; Andrea Tannapfel; Bernhard F Henning
Journal:  J Med Case Rep       Date:  2009-09-08

10.  Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism.

Authors:  Elsnoussi Ali Hussin Mohamed; Mohammad Jamshed Ahmad Siddiqui; Lee Fung Ang; Amirin Sadikun; Sue Hay Chan; Soo Choon Tan; Mohd Zaini Asmawi; Mun Fei Yam
Journal:  BMC Complement Altern Med       Date:  2012-10-08       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.